Browsing by Author "Byamungu Pahari Kagenderezo"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    A Systematic Review on Hypertension and its Management
    (International Journal of Innovative and Applied Research, 2022) Emmanuel Ifeanyi Obeagu; Byamungu Pahari Kagenderezo; Getrude Uzoma Obeagu
    Hypertension is a public health problem which has cut across all spheres of life and walks of life. From the literature review, the researcher has found that most hypertensive patients are less engaged in healthy behaviours because of knowledge deficit. The literature reviews also indicated that gender, age, level of education, lifestyle, and compliance to treatment regimen had significant association with healthy behaviours in patients with hypertension.
  • Thumbnail Image
    Item
    An Insight of Interleukin -6 and Fibrinogen: In Regulating the Immune System
    (Journal of Biomedical Sciences, 2022) Emmanuel Ifeanyi Obeagu; Emmanuel Muhimbura; Byamungu Pahari Kagenderezo; Sarah Nakyeyune; Getrude Uzoma Obeagu
    The role of the liver as a critical part of the immune system involved in both innate and adaptive immunity. As a major source of acute phase proteins, including components of the complement system. Hepatocytes are an important part of innate immunity and play an important role in controlling inflammatory responses throughout the body. Acute-phase protein production in hepatocytes is controlled by various cytokines released during the inflammatory process, with IL-6 and IL-1 type cytokines acting as key regulators, cascading and synergistic regulation or it functions as a cascade network with inhibition. Effects on acute-phase protein expression. The pro inflammatory cytokine interleukin-6 is an endogenous biochemical active during B cell maturation and inflammatory processes. Interleukin-6 plays an important role in regulating acute-phase protein synthesis in human hepatocytes.
  • Thumbnail Image
    Item
    An Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia Crisis
    (Journal of Biomedical Sciences, 2022) Emmanuel Ifeanyi Obeagu; Byamungu Pahari Kagenderezo; Onyekachi Splendid Uwakwe; Sarah Nakyeyune; Getrude Uzoma Obeagu
    Sickle cell disease has been described by many scholars as a chronic inflammatory disease which is linked to many factors such as endothelial destruction, increased synthesis of reactive oxygen specie, haemolysis, increased synthesis of pro inflammatory cytokines among others. Inflammatory process play a major function in the activation of acute painful vaso-occlusion crisis that forms the main reason for the hospitalization of patients with sickle cell anaemia. Inflammatory processes, are key components of several complications of the disease including autosplenectomy, acute chest syndrome, pulmonary hypertension, leg ulcer, nephropathy and stroke and also ultimately initiates painful vaso-occlusion episodes that characterize Sickle Cell Disease. This study titled “Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia in Crises, aims at finding out the recent updates on interferon gamma; a pro-inflammatory cytokine that plays a central role in inflammation and auto-immunity, and CRP; an acute phase protein used as a marker of inflammation in sickle cell anaemia patients in crisis. A lot of search engines were consulted in the course of writing this review such as scopus, Pubmed Central, Web of Science, Semantics, Google Scholar, Researchgate, Academia Edu, etc. Previous studies have suggested that levels of pro-inflammatory cytokines vary between steady-state and crisis states in SCA patients, hypothesized to help monitor clinical progression of the disease. . Newer therapies that target pathways downstream of the sickle are considered better options. This knowledge may have implications for the development of new treatments for sickle cell disease.